Patrick R. O'Neil is EVP CLO & General Counsel of IONIS PHARMACEUTICALS INC. Currently has a direct ownership of 48,873 shares of IONS, which is worth approximately $1.84 Million. The most recent transaction as insider was on Aug 30, 2024, when has been sold 246 shares (Common Stock) at a price of $38.64 per share, resulting in proceeds of $9,505. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.9K
0% 3M change
21.11% 12M change
Total Value Held $1.84 Million

PATRICK R. O'NEIL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 30 2024
BUY
Other acquisition or disposition
$9,505 $38.64 p/Share
246 Added 0.5%
48,873 Common Stock
Feb 02 2024
SELL
Open market or private sale
$97,402 $49.67 p/Share
1,961 Reduced 3.87%
48,661 Common Stock
Feb 01 2024
BUY
Grant, award, or other acquisition
-
3,820 Added 7.02%
50,622 Common Stock
Jan 25 2024
SELL
Open market or private sale
$333,787 $51.75 p/Share
6,450 Reduced 12.11%
46,802 Common Stock
Jan 17 2024
SELL
Open market or private sale
$390,452 $50.42 p/Share
7,744 Reduced 12.7%
53,252 Common Stock
Jan 16 2024
BUY
Exercise of conversion of derivative security
-
20,641 Added 25.28%
60,996 Common Stock
Dec 26 2023
SELL
Open market or private sale
$1,071,654 $51.46 p/Share
20,825 Reduced 34.04%
40,355 Common Stock
Dec 26 2023
BUY
Exercise of conversion of derivative security
$985,855 $47.34 p/Share
20,825 Added 25.39%
61,180 Common Stock
May 24 2023
SELL
Open market or private sale
$63,675 $41.7 p/Share
1,527 Reduced 3.65%
40,355 Common Stock
Feb 28 2023
BUY
Other acquisition or disposition
$9,186 $30.52 p/Share
301 Added 0.71%
41,882 Common Stock
Feb 06 2023
SELL
Open market or private sale
$78,451 $40.86 p/Share
1,920 Reduced 4.41%
41,581 Common Stock
Feb 03 2023
BUY
Grant, award, or other acquisition
-
3,822 Added 8.08%
43,501 Common Stock
Jan 31 2023
SELL
Open market or private sale
$178,695 $39.71 p/Share
4,500 Reduced 10.19%
39,679 Common Stock
Jan 30 2023
SELL
Open market or private sale
$177,390 $39.42 p/Share
4,500 Reduced 9.24%
44,179 Common Stock
Jan 18 2023
SELL
Open market or private sale
$309,443 $39.49 p/Share
7,836 Reduced 13.87%
48,679 Common Stock
Jan 17 2023
BUY
Exercise of conversion of derivative security
-
21,871 Added 27.9%
56,515 Common Stock
Aug 31 2022
BUY
Other acquisition or disposition
$3,129 $28.97 p/Share
108 Added 0.31%
34,644 Common Stock
Apr 12 2022
SELL
Open market or private sale
$272,088 $40.06 p/Share
6,792 Reduced 16.43%
34,536 Common Stock
Feb 28 2022
BUY
Other acquisition or disposition
$20,852 $28.37 p/Share
735 Added 1.75%
41,328 Common Stock
Jan 18 2022
SELL
Payment of exercise price or tax liability
$225,930 $30.12 p/Share
7,501 Reduced 15.6%
40,593 Common Stock
Jan 18 2022
BUY
Exercise of conversion of derivative security
-
21,086 Added 30.48%
48,094 Common Stock
Aug 31 2021
BUY
Other acquisition or disposition
$10,444 $33.8 p/Share
309 Added 1.13%
27,008 Common Stock
Feb 26 2021
BUY
Other acquisition or disposition
$8,774 $44.54 p/Share
197 Added 0.73%
26,699 Common Stock
Jan 25 2021
SELL
Open market or private sale
$338,074 $63.5 p/Share
5,324 Reduced 16.73%
26,502 Common Stock
Jan 15 2021
SELL
Payment of exercise price or tax liability
$358,856 $61.28 p/Share
5,856 Reduced 15.54%
31,826 Common Stock
PRO

Patrick R. O'Neil

EVP CLO & General Counsel
Carlsbad, CA

Track Institutional and Insider Activities on IONS

Follow IONIS PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IONS shares.

Notify only if

Insider Trading

Get notified when an Ionis Pharmaceuticals Inc insider buys or sells IONS shares.

Notify only if

News

Receive news related to IONIS PHARMACEUTICALS INC

Track Activities on IONS